title: Functional improvement precedes structural regression of atherosclerosis.
abstract: BACKGROUND
  Vasoconstrictor responses to serotonin are augmented in monkeys with diet-induced atherosclerosis and improve after 18 months of normal diet. We tested the hypothesis that functional improvement may occur early during regression, before evidence of structural improvement.
  
  
  RESULTS
  Responses of the iliac artery to serotonin were measured by quantitative angiography and a Doppler flow probe in several groups of monkeys: (1) normal monkeys, (2) monkeys fed an atherogenic diet for 2 years (atherosclerotic), and (3) monkeys fed an atherogenic diet for 2 years (preregression) followed by a normal diet for 4, 8, or 12 months (regression). In normal monkeys, serotonin produced minimal constriction of the iliac artery, and blood flow to the legs increased. In atherosclerotic monkeys, there was pronounced constriction of the iliac artery, and blood flow to the legs decreased markedly. After 4 months of regression diet, four of eight monkeys demonstrated marked reduction in hyperresponsiveness to serotonin angiographically, and by 8 months, six of eight monkeys had significant improvement. After regression, serotonin produced minimal changes in flow. There was no reduction in intimal area (ie, atherosclerotic lesion) in iliac arteries from regression monkeys compared with atherosclerotic monkeys, but there was a marked reduction in cholesteryl ester in arteries from regression monkeys.
  
  
  CONCLUSIONS
  Abnormal vasoconstrictor responses to serotonin usually return to or toward normal within a few months during regression of atherosclerosis. Functional improvement occurs in conjunction with early resorption of lipid from the arterial wall and occurs before detectable changes in mass of the atherosclerotic lesion.
authors.affiliation: Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242-1081.
authors.forename: K H
authors.initials: KH
authors.lastname: Benzuly
authors.forename: R C
authors.initials: RC
authors.lastname: Padgett
authors.forename: S
authors.initials: S
authors.lastname: Kaul
authors.forename: D J
authors.initials: DJ
authors.lastname: Piegors
authors.forename: M L
authors.initials: ML
authors.lastname: Armstrong
authors.forename: D D
authors.initials: DD
authors.lastname: Heistad
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000178:diet therapy / Q000473:pathology / Q000503:physiopathology*; D002784:Cholesterol / Q000097:blood; D004036:Diet, Atherogenic; D006937:Hypercholesterolemia / Q000503:physiopathology; D007083:Iliac Artery / Q000473:pathology / Q000503:physiopathology*; D007866:Leg / Q000098:blood supply; D008252:Macaca fascicularis; D008297:Male; D012039:Regional Blood Flow / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology; D013997:Time Factors; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*
chemical_list: D012701:Serotonin; D002784:Cholesterol